Paradigm Biopharmaceuticals Financial Overview
Paradigm Biopharmaceuticals's market cap is currently $90.90M. The company's EPS TTM is $-0.0218757; its P/E ratio is -7.03; Paradigm Biopharmaceuticals is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
